INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 145 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 2.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $26,592 | -7.9% | 841 | +18.8% | 0.00% | 0.0% |
Q2 2023 | $28,872 | -2.2% | 708 | -10.6% | 0.00% | 0.0% |
Q1 2023 | $29,518 | +166.0% | 792 | +149.1% | 0.00% | – |
Q4 2022 | $11,095 | -38.4% | 318 | +1.0% | 0.00% | -100.0% |
Q3 2022 | $18,000 | +20.0% | 315 | +9.0% | 0.00% | 0.0% |
Q2 2022 | $15,000 | -21.1% | 289 | +11.6% | 0.00% | 0.0% |
Q1 2022 | $19,000 | -44.1% | 259 | -9.1% | 0.00% | 0.0% |
Q4 2021 | $34,000 | -5.6% | 285 | +4.8% | 0.00% | 0.0% |
Q3 2021 | $36,000 | -29.4% | 272 | -13.7% | 0.00% | -50.0% |
Q2 2021 | $51,000 | +82.1% | 315 | -10.0% | 0.00% | +100.0% |
Q1 2021 | $28,000 | +100.0% | 350 | +40.0% | 0.00% | 0.0% |
Q4 2020 | $14,000 | +366.7% | 250 | +55.3% | 0.00% | – |
Q3 2020 | $3,000 | +50.0% | 161 | +61.0% | 0.00% | – |
Q2 2020 | $2,000 | -60.0% | 100 | -76.9% | 0.00% | – |
Q1 2020 | $5,000 | +150.0% | 432 | +319.4% | 0.00% | – |
Q4 2019 | $2,000 | +100.0% | 103 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | -50.0% | 103 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 103 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | +100.0% | 103 | +3.0% | 0.00% | – |
Q4 2018 | $1,000 | -66.7% | 100 | 0.0% | 0.00% | – |
Q3 2018 | $3,000 | -80.0% | 100 | -81.8% | 0.00% | -100.0% |
Q2 2018 | $15,000 | +66.7% | 550 | +22.2% | 0.00% | +100.0% |
Q1 2018 | $9,000 | – | 450 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |